Ceridian HCM (CDAY) Tops Q4 EPS by 11c

Ceridian HCM (NYSE: CDAY) reported Q4 EPS of $0.23, $0.11 better than the analyst estimate of $0.12. Revenue for the quarter came in at $336.1 million versus the consensus estimate of $325.03 million.

For earnings history and earnings-related data on Ceridian HCM (CDAY) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Pan American Silver (PAAS) Misses Q2 EPS by 19c
• Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c